PRIORIX

Product Overview

About PRIORIX

PRIORIX is a live, attenuated vaccine designed to provide immunity against measles, mumps, and rubella. It is a combination vaccine that contains three active ingredients: Rubella Virus Live Attenuated (Wistar RA27/3 strain), Measles Virus Live Attenuated (Schwarz strain), and Mumps Virus Live Attenuated (RIT 4385 strain). PRIORIX is used to protect against these viral infections, which can cause serious complications, especially in young children and individuals with weakened immune systems.

Key Benefits & Uses

• Provides immunity against measles, mumps, and rubella
• Protects against serious complications associated with these viral infections
• Recommended for use in children and individuals with weakened immune systems

Active Ingredient & Action

The active ingredients in PRIORIX are live, attenuated viruses that have been weakened to prevent infection while still stimulating the body's immune response. When administered, these viruses trigger an immune response, producing antibodies that help to neutralize the viruses and prevent infection. The Wistar RA27/3 strain of Rubella Virus, the Schwarz strain of Measles Virus, and the RIT 4385 strain of Mumps Virus work together to provide comprehensive protection against these viral infections.

Important Notes

PRIORIX should only be administered by a healthcare professional. It is essential to follow the recommended dosing schedule and to report any adverse reactions to your healthcare provider. As with any vaccine, PRIORIX may cause side effects, such as pain, redness, or swelling at the injection site, fever, or fatigue. If you have any underlying medical conditions or are taking medications that may interact with PRIORIX, consult your healthcare provider before administration.